(NASDAQ:CYTK), Regulatory Reviews of Aficamten for Obstructive HCM Progressing in U.S., E.U. and China; Late-Cycle Meeting with U.S. FDA Scheduled for September Ahead of December 26, 2025 PDUFA Date Primary Results from MAPLE-HCM to be Presented in a Hot Line Session at the European Society of Cardiology Congress 2025 ~$1.0 Billion in Cash, Cash Equivalents […]
(NASDAQ:MRM), Creating new social infrastructure in collaboration with HakuhodoTo promote the spread of World ID in Japan,Verification Device”Orb”will be installed in 100 Re.Ra.Ku relaxation salons. TOKYO, Aug. 07, 2025 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM; hereinafter referred to as “MEDIROM”) has collaborated with Hakuhodo Inc. to
(NASDAQ:PDFS), SANTA CLARA, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of comprehensive data solutions for the semiconductor and electronics ecosystem, today announced financial results for its second quarter ended June 30, 2025. Financial Highlights of Second Quarter 2025 Record quarterly total revenues of $51.7 million, up 24%
Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lineage, Inc. (“Lineage” or “the Company”) (NASDAQ: LINE) and certain of its officers. https://mma.prnewswire.com/media/439152/Bronstein_Gewirtz_and_Grossman_LLC_logo.jpg Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on
(NASDAQ:NEPH), SOUTH ORANGE, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) — Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the second quarter ended June 30, 2025. Financial Highlights Net revenue was $4.4 million, compared to $3.3 million in the second quarter
(NASDAQ:ATYR), SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced second quarter 2025 results and provided a corporate update. “With the recent completion of the
(NASDAQ:INAB), Delivered an oral presentation at ASCO 2025 Annual Meeting, demonstrating extended median progression-free survival (mPFS) in patients receiving multiple doses of INB-200, including a patient remaining progression-free for over four years. Received the Host Region USA East Abstract Award at ISCT 2025 for IN8bio's DeltEx(TM) manufacturing platform. Presented preclinical data at ASGCT 2025 on
Goodwill Industries of Greater New York and Northern New Jersey (GoodwillNYNJ) is proud to announce two key additions to its executive leadership team, reinforcing the organization's commitment to growth, innovation, and its mission of creating sustainable opportunities for all. https://mma.prnewswire.com/media/2746433/Goodwill_NYNJ_Samantha_Rich.jpg Samantha Rich Promoted to Executive Vice President of Donated Goods RetailAfter a comprehensive national search,
(NasdaqGM:ALT), NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Altimmune, Inc. (“Altimmune” or “the Company”) (NASDAQ: ALT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for
(NYSE:VSTS), NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Vestis Corporation (“Vestis” or “the Company”) (NYSE: VSTS) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants